Riverview Capital Advisers’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,431
Closed -$255K 79
2023
Q1
$255K Buy
3,431
+23
+0.7% +$1.93K 0.11% 74
2022
Q4
$318K Buy
3,408
+18
+0.5% +$1.74K 0.17% 62
2022
Q3
$323K Buy
3,390
+187
+6% +$18.5K 0.2% 65
2022
Q2
$297K Buy
3,203
+18
+0.6% +$1.76K 0.16% 68
2022
Q1
$322K Sell
3,185
-20,549
-87% -$2.16M 0.15% 69
2021
Q4
$2.45M Buy
+23,734
New +$2.19M 1.09% 29

Other funds holding CVS

Riverview Capital Advisers's CVS Position: Q2 2023 in Review

Riverview Capital Advisers sold out of CVS Health (CVS) in Q2 2023, closing a stake of 3,431 shares — an estimated $255K sold.

Riverview Capital Advisers first reported a position in CVS in Q4 2021 and held it in 6 quarters. The position peaked at $2.45M in Q4 2021. 2,204 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Riverview Capital Advisers reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Riverview Capital Advisers sold 3,431 CVS Health shares in Q2 2023, an estimated $255K.
  • Riverview Capital Advisers first reported a position in CVS Health in Q4 2021 and held it in 6 quarters.
  • Riverview Capital Advisers's CVS Health position peaked at $2.45M in Q4 2021.
  • 2,204 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Riverview Capital Advisers's 13F filing for Q2 2023, filed 4 Aug 2023.